Table 3.
Characteristics | Total | Serum PTN | ||
---|---|---|---|---|
Higha | Lowb | P‐value | ||
Age, y | 0.472 | |||
≥60 | 70 | 38 | 32 | |
<60 | 58 | 36 | 22 | |
Gender | 0.373 | |||
Male | 60 | 32 | 28 | |
Female | 68 | 42 | 26 | |
Smoking status | 0.211 | |||
Non‐smoker | 72 | 38 | 34 | |
Smoker | 56 | 36 | 20 | |
Performance status | 0.462 | |||
0‐1 | 80 | 44 | 36 | |
2‐3 | 48 | 30 | 18 | |
Disease stage | 0.001* | |||
Limited | 58 | 24 | 34 | |
Extended | 70 | 50 | 20 |
PTN, pleiotrophin.
High group represents the levels of serum PTN ≥ 258.18 ng/mL.
Low group represents the levels of serum PTN < 258.18 ng/mL.
Statistically significant difference (P < 0.05)